Table 2.
Postnatal morbidity between 1 and 2 years of age of children contributing to INTERGROWTH-21st international INTER-NDA standards
| Morbidity between 1 and 2 years of life | Children contributing to INTERGROWTH-21st international INTER-NDA standards (n=1209) |
| Hospitalised at least once | 113 (9.4) |
| Total no of days hospitalised* | 2 (1–3) |
| Any prescription provided by a healthcare practitioner | 712 (59.1) |
| Antibiotics (≥3 regimens) | 142 (11.8) |
| Iron/folic acid/vitamin B12/other vitamins | 194 (16.1) |
| Up to date with local vaccination policies | 1136 (94.4) |
| Otitis media/pneumonia/bronchiolitis | 88 (7.3) |
| Parasitosis/diarrhoea/vomiting | 43 (3.6) |
| Exanthema/skin disease | 150 (12.5) |
| Urinary tract infection/pyelonephritis | 5 (0.4) |
| Fever ≥3 days (≥3 episodes) | 134 (11.1) |
| Other infections requiring antibiotics | 40 (3.3) |
| Asthma | 13 (1.1) |
| Gastro-oesophageal reflux | 3 (0.2) |
| Cow’s milk protein allergy | 8 (0.7) |
| Food allergies | 13 (1.1) |
| Injury or trauma | 27 (2.2) |
| Any condition requiring surgery | 9 (0.7) |
Data are number (%) unless otherwise specified.
Missing data below 2% for all variables.
*Median (IQR).
INTER-NDA, INTERGROWTH-21st Neurodevelopment Assessment.